Xenon Pharmaceuticals (XENE) Net Margin (2013 - 2025)
Xenon Pharmaceuticals (XENE) reported Net Margin of 867.29% for Q1 2025, up 96.92% quarter-over-quarter from 28143.94% in Q3 2022.
Xenon Pharmaceuticals (XENE) Net Margin (2013 - 2025) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 10 years of Net Margin data on file, last reported at 867.29% in Q1 2025.
- Net Margin for Q1 2025 came in at 867.29%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 26.09% (changed N/A YoY), and the FY2025 annual result was 26.09%, changed N/A from the prior year.
- Net Margin rose to 867.29% in Q1 2025 per XENE's latest filing, from 28143.94% in the prior quarter.
- Over five years, Net Margin peaked at 220.98% in Q1 2022 and troughed at 28143.94% in Q3 2022.
- A 3-year average of 4672.1% and a median of 769.17% in 2021 frame the typical range for Net Margin.
- On a YoY basis, Net Margin climbed as much as 13104 bps in 2022 and fell as far as 2780876 bps in 2022.
- A 3-year view of Net Margin shows it stood at 671.05% in 2021, then plunged by 4094 bps to 28143.94% in 2022, then jumped by 97 bps to 867.29% in 2025.
- Business Quant data shows XENE's Net Margin at 867.29% in Q1 2025, 28143.94% in Q3 2022, and 5813.06% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -867.29% |
| Sep 30, 2022 | -28,143.94% |
| Jun 30, 2022 | -5,813.06% |
| Mar 31, 2022 | -220.98% |
| Dec 31, 2021 | -671.05% |
| Sep 30, 2021 | -335.18% |
| Jun 30, 2021 | -973.31% |
| Mar 31, 2021 | -352.02% |
| Dec 31, 2020 | -232.49% |
| Sep 30, 2020 | -131.29% |
| Jun 30, 2020 | -1.27% |
| Mar 31, 2020 | -102.60% |
| Dec 31, 2019 | -329.05% |
| Sep 30, 2019 | -243.86% |
| Dec 31, 2017 | -49,725.00% |
| Sep 30, 2017 | -3,227.27% |
| Jun 30, 2017 | -51,893.33% |
| Mar 31, 2017 | -46,981.25% |
| Dec 31, 2016 | -1,407.98% |
| Sep 30, 2016 | -1,747.46% |